Here, we demonstrated that pharmacological inhibition of the malate-aspartate shuttle reduced viability in resistant GLUL KO A549 cells compared to control cells, thus connecting malate-aspartate metabolism with drug tolerance in cancer cells. The gene discussed is GLUL; the disease is cancer.